Search Within

Walid Khaled Chatila

  1. "Biostatistics Service"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (7)
Groups
  1. Biostatistics Service (28)
  2. Computational Oncology Service (28)
  3. Department of Medicine (28)
  4. Epidemiology and Biostatistics (28)
  5. MSK Grad Students (28)
  6. Solid Tumor Oncology Division (28)

More Groups

People
  1. Nikolaus Schultz (25)
  2. David Solit (17)
  3. Marinela Capanu (14)
  4. Michael Berger (14)
  5. Francisco Sanchez Vega (11)
  6. Henry Walch (11)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Clinical Cancer Research (7)
  2. Journal of Clinical Oncology (6)
  3. Annals of Surgery (3)
  4. Annals of Surgical Oncology (2)
  5. Clinical Colorectal Cancer (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (7)
  3. Lippincott Williams & Wilkins (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. Springer (2)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distinct genomic profiles are associated with conversion to resection and survival in patients with initially unresectable colorectal liver metastases treated with systemic and hepatic artery chemotherapy
    Journal Article

    Datta, J.; Narayan, R. R.; Goldman, D. A.; Chatila, W. K.; Gonen, M.; Strong, J.; Balachandran, V. P.; Drebin, J. A.; Kingham, T. P.; Jarnagin, W. R.; more...
    Annals of Surgery (2022)

    Fulltext@MSK | Save
  • Same-cell co-occurrence of RAS hotspot and BRAF V600E mutations in treatment-naive colorectal cancer
    Journal Article

    Gularte-MeĢrida, R.; Smith, S.; Bowman, A. S.; da Cruz Paula, A.; Chatila, W.; Bielski, C. M.; Vyas, M.; Borsu, L.; Zehir, A.; Martelotto, L. G.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights
    Journal Article

    Alatise, O. I.; Knapp, G. C.; Sharma, A.; Chatila, W. K.; Arowolo, O. A.; Olasehinde, O.; Famurewa, O. C.; Omisore, A. D.; Komolafe, A. O.; Olaofe, O. O.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant hepatic arterial infusion and systemic therapy with or without panitumumab after hepatic resection of KRAS wild-type colorectal cancer
    Journal Article

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Chatila, W. K.; Shi, H.; Sanchez-Vega, F.; Kingham, T. P.; Connell, L. C.; Jarnagin, W. R.; D'Angelica, M. I.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; Sanchez-Vega, F.; Chatila, W. K.; De La Torre, S. A.; Patel, A.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: Matched case cohort analysis
    Journal Article

    Yaeger, R.; Paroder, V.; Bates, D. D. B.; Capanu, M.; Chou, J.; Tang, L.; Chatila, W.; Schultz, N.; Hersch, J.; Kelsen, D.
    Clinical Colorectal Cancer (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save